Search Browse Earnings

Theravance Biopharma, Inc. — SlamSEC

Theravance Biopharma, Inc.

Nasdaq:TBPH

Pharmaceutical Preparations·GEORGE TOWN, GRAND CAYMAN, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$10.4M

-21.1% YoY

FY 2024

Adj. EBITDA

-$21.8M

-209.2% margin

FY 2024

Net Income

-$22.1M

-212.0% margin

FY 2024

EPS (Diluted)

-$0.35

FY 2024

Stock Price

$13.78

-0.8%

2026-03-13

52W Range

$7.90 – $21.03

P/E Ratio

-39.4x

Market Cap

$698.3M

Cash

$39.5M

FY 2024

Total Debt

—

Net Cash

$39.5M

FY 2023

Enterprise Value

$658.7M

Debt / EBITDA

1.8x

FY 2024

EV / EBITDA

-30.2x

Employees

—